Loading clinical trials...
Loading clinical trials...
Finger Worn Detection Via Electrocardiographic Ring of Atrial Fibrillation and ECG Waveform Analysis (FINDER-AF)
Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.
In this study the participant will obtain a simultaneous electrocardiogram from both the everbeat ring system and a clinical-grade diagnostic ECG machine for correlation and analysis.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
XIMED
La Jolla, California, United States
Our Lady of Lake Hospital
Baton Rouge, Louisiana, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Start Date
September 17, 2024
Primary Completion Date
March 12, 2025
Completion Date
April 1, 2025
Last Updated
March 27, 2025
232
ACTUAL participants
Atrial Fibrillation Identification
DIAGNOSTIC_TEST
Lead Sponsor
Everbeat
NCT06935591
NCT07430007
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07272902